TW201116623A - Extracellular polysaccharides with arabinose from Trametes versicolor LH1 and enhancing their production methods - Google Patents

Extracellular polysaccharides with arabinose from Trametes versicolor LH1 and enhancing their production methods Download PDF

Info

Publication number
TW201116623A
TW201116623A TW98137173A TW98137173A TW201116623A TW 201116623 A TW201116623 A TW 201116623A TW 98137173 A TW98137173 A TW 98137173A TW 98137173 A TW98137173 A TW 98137173A TW 201116623 A TW201116623 A TW 201116623A
Authority
TW
Taiwan
Prior art keywords
peptide
arabinose
extracellular
yunzhi
liquid medium
Prior art date
Application number
TW98137173A
Other languages
Chinese (zh)
Other versions
TWI379001B (en
Inventor
Fang-Yi Lin
Tai-Hao Hsu
Original Assignee
Univ Dayeh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dayeh filed Critical Univ Dayeh
Priority to TW98137173A priority Critical patent/TWI379001B/en
Publication of TW201116623A publication Critical patent/TW201116623A/en
Application granted granted Critical
Publication of TWI379001B publication Critical patent/TWI379001B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention related to the extracellular polysaccharopeptides with arabinose from submerged fermentation with adding trace Scutellaria barbata extracts by a local Trametes versicolor strain LH1 that exhibit significantly enhancing immunomodulatory activity and increasing production.

Description

201116623 六、發明說明: 【發明所屬之技術領域】 本發明所屬之技術領域為藥用菌類多醣肽,更特定而 吕,係關於具有阿拉伯糖之雲芝胞外多黯肽及促進其生產之 方法與含彼之組合物,可用以調節免疫活性。 【先前技術】 雲之學名為 Trametes versicolor {syn. Coriolus vaj/co/or),寄生於腐木,為白色菌絲體,生長分佈於全世 界’是一種廣泛使用之藥用真菌(Wasser,& Weis,1999)。雲 芝子實體生長缓慢’且價格昂貴。以液態培養方式所生產之 雲芝多醣肽已知具有免疫調節與抗腫瘤之生物活性(Cui,& Chisti, 2003).。雲芝多醋肽可從不同雲芝品系如 CM-l〇i(ATCC 20547)或 Cov-1 分離(Kobayashi,Matsunaga,& Fujii,1993 ; Cui,& Chisti,.2003 ; Moradali,Mostafavi, Ghods, & Hediaroude,2007)。多醣肽中之多醣體以 4)及 β(ι—3) 之鍵結’於體外、體内及臨床實驗上已證實其具免疫調節活 性(Hsieh, Wu,Park, & Wu,2006)。從雲芝菌株 Cov-1 品系製 備所得之多醣肽可增加免疫細胞介白素IL-Ιβ及IL-6之分 /必1 ’且誘發人類HL-60淋·巴癌細胞之細胞〉周亡(apoptosis) (Hsieh, Kunicki, Darzynkiewicz,& Wu,2002) ° 動物體内實驗中,從餵食多醣肽之老鼠分離出之巨噬細 201116623 胞,含有活性氮中間體(reactive nitrogen intermediates, RNI)、超氧化物陰離子(superoxide anions)及腫瘤壞死因子 -7(Tumor Necrosis Factor-γ » TNF-γ) (Liu, Ng, Sze, & Tsui,201116623 VI. Description of the invention: [Technical field to which the invention pertains] The technical field to which the present invention pertains is a medicinal fungus polysaccharide peptide, which is more specific, and relates to an extracellular glycopeptide having an arabinose and a method for promoting the production thereof. Compositions containing the same can be used to modulate immunological activity. [Prior Art] The name of the cloud is Trametes versicolor {syn. Coriolus vaj/co/or), which is parasitic on rot, is a white mycelium, and is distributed throughout the world. It is a widely used medicinal fungus (Wasser, & Weis, 1999). Yunzhi fruiting bodies grow slowly' and are expensive. The Yunzhi polysaccharide peptide produced by liquid culture is known to have immunomodulatory and antitumor biological activities (Cui, & Chisti, 2003). Yunzhi polyacetate can be isolated from different Yunzhi lines such as CM-l〇i (ATCC 20547) or Cov-1 (Kobayashi, Matsunaga, & Fujii, 1993; Cui, &Chisti,.2003; Moradali, Mostafavi, Ghods, & Hediaroude, 2007). The polysaccharides in the polysaccharide peptide have been shown to have immunomodulatory activity in vitro, in vivo and in clinical experiments with 4) and β(ι-3) linkages (Hsieh, Wu, Park, & Wu, 2006). The polysaccharide peptide prepared from the Yunzhi strain Cov-1 strain can increase the division of IL-Ιβ and IL-6 in the immune cells and induce cells of human HL-60 lymphocytes. Apoptosis) (Hsieh, Kunicki, Darzynkiewicz, & Wu, 2002) ° In vivo experiments in animals, macrophages 201116623 isolated from mice fed polysaccharide peptide, containing reactive nitrogen intermediates (RNI), Superoxide anions and Tumor Necrosis Factor-γ » TNF-γ (Liu, Ng, Sze, & Tsui,

1 993)。雲芝的多_月太可以活化巨嗤細胞、刺激分泌細胞激素 TNF-γ、干擾素-γ ( Interferon-γ,IFN-γ )及介白素-1β (Interleukin-1 β, IL-1 β ),這些細胞激素係用以對抗細胞增生 及引起細胞凋亡及分化。雲芝多醣肽可引起免疫系統非專一 性防禦及透過服用者本身免疫系統進而產生抗腫瘤作用(Cui, & Chisti,2003; Ng,1998)。 半枝蓮()為一種多年生中草藥,廣 泛分佈於南中國及韓國,常被用於抗發炎、利尿與抗腫瘤, 尤其是肝癌、肝炎及肝硬化之治療(Wang, & Lu,2005),最近 從半枝蓮萃取物中分離出類黃酮(flavonoids )及二萜類 (diterpernoids )的新克羅院(neoclerodane )、三萜酸 (triterpenic acid ).及谷 甾 醇 葡 萄_武 (phytosteryl-p-D-glucoside )等具有生物活性(Wang, Xu,Yan, & Zhu, 1996; Ducki, Hadfield, Lawrence, Liu, McGown, & Zhang, 1996; Kizu, Imoto, Tomimori, Kikuchi, Kadota, & Tsubono, 1997; Yu,& Lei,2004; Yin,Zhou,& Jie,2004)。且 在小鼠肝癌H22細胞上也發現半枝蓮萃取物可抑制癌細胞 增生,且可做為化學治療的辅助劑(Dai, Liu, Ji,Liu,Kang, Wang,& Diao, 2008)。半枝蓮萃取物中所得多醣體為重要生 201116623 物活性成分,在動物試驗中明顯具抗氧化活性(王志遠,戴玲, &張凱,2008)及免疫調節功能(林敬明,劉煌,&羅榮城, 2006)〇 一般真菌深層發酵槽培養,其菌絲體生長及胞外多醣肽 生產受培養條件環境及培養基組成影響。以牛肝菌(万deiws spp )為例,進行培養所產生之菌絲體及胞外多醣肽受如溫 度、攪拌速度及起始pH值等因子影響(Wang, & Lu,2005)。 不同雲芝菌株品系Wr-74和ATCC-20545 ’利用乳清添加於 培養基中可影響其菌絲體及胞外多醣肽之產量(Cui, Goh, Archer, & Singh, 2007)。胞外多醣肽之化學組成和特性會受 到培養基成分之影響’例如Chen,Hsu, Lin,Lai,and Wu (2006)利用不同碳源之培養基,培養, 所得之胞外多醣肽會產生不同單醣組成,其胞外多醣肽會刺 激巨噬細胞RAW264.7產生不同量之一氧化氮及細胞激素。 【發明内容】 本案發明人自台灣南投山區採集不同雲芝子實體,經分 離培養後發現其中一雲芝菌株品系LH-1,生長快速且菌絲體 產量高,經食品工業發展研究所生物資源保存中心鑑定其學 名為TVameies verhco/or (L.)Lloyd【菌種鑑定報告如附送書 件】,研究發現能產生新穎胞外多醣肽(簡稱ePSP-Cv),且在 所採用之培養基條件下具有較高之產物比生成率與促進細 201116623 胞激素分泌之免疫調節活性,其中該細胞激素為腫瘤壞死因 子-a ( TNF-a )。於培養基中添加微量半枝蓮(Scwie/Zarifl 萃取液(簡稱SBE),更可顯著提高雲芝胞外多醣 肽(簡稱ePSP-Cv-SBE)產物比生成率及免疫調節生物活性, 該免疫調節活性包含促進巨噬細胞增生、促進巨噬細胞一氧 化氮產生及促進細胞激素分泌量;其中該細胞激素為腫瘤壞 死因子-a(TNF_a)、介白素-ip(IL-lp)及介白素_6(IL_6)。 【實施方式】 .雲芝(TVflw以a T TT1) 目前寄存於財團法人食品工業發展研究所生物資源保 存中心’寄存編號為BCRC930112。 半枝蓮萃取液(SBE、 )比例加水煮沸後, 得到半枝蓮萃取液 將乾燥半枝蓮以1 (半枝蓮):10 (水1 993). Yunzhi's multi-month can activate giant sputum cells, stimulate the secretion of cytokines TNF-γ, interferon-γ (IFN-γ) and interleukin-1β (Interleukin-1 β, IL-1 β These cytokines are used to fight cell proliferation and cause apoptosis and differentiation. Yunzhi polysaccharide peptide can cause non-specific defense of the immune system and produce anti-tumor effects through the user's own immune system (Cui, & Chisti, 2003; Ng, 1998). Scutellaria barbata L. is a perennial herbal medicine widely distributed in South China and South Korea. It is often used for anti-inflammatory, diuretic and anti-tumor, especially for the treatment of liver cancer, hepatitis and cirrhosis (Wang, & Lu, 2005). Recently, flavonoids and diterpernoids have been isolated from the scutellaria extract (nevonerodines), triterpenic acid, and phytosteryl-pD- Glucose) and other biological activities (Wang, Xu, Yan, & Zhu, 1996; Ducki, Hadfield, Lawrence, Liu, McGown, & Zhang, 1996; Kizu, Imoto, Tomimori, Kikuchi, Kadota, & Tsubono, 1997 Yu, &Lei;2004; Yin, Zhou, & Jie, 2004). Furthermore, Scutellaria barbata extract can inhibit cancer cell proliferation in mouse liver cancer H22 cells and can be used as an adjuvant for chemotherapy (Dai, Liu, Ji, Liu, Kang, Wang, & Dia Dia, 2008). The polysaccharide obtained from Scutellaria barbata L. extract is an important active ingredient of 201116623, which has significant antioxidant activity in animal experiments (Wang Zhiyuan, Dai Ling, & Zhang Kai, 2008) and immune regulation function (Lin Jingming, Liu Huang, & Luo Rongcheng, 2006) The cultivation of general fungal deep fermentation tanks, the growth of mycelium and the production of extracellular polysaccharide peptide are affected by the culture conditions and medium composition. Taking Boletus edulis (wan deiws spp) as an example, the mycelium and extracellular polysaccharide peptides produced by the culture are affected by factors such as temperature, stirring speed and initial pH (Wang, & Lu, 2005). Different strains of Yunzhi strain Wr-74 and ATCC-20545' can be affected by the addition of whey to the medium (Cui, Goh, Archer, & Singh, 2007). The chemical composition and properties of the extracellular polysaccharide peptide are affected by the composition of the medium. For example, Chen, Hsu, Lin, Lai, and Wu (2006) use a medium with different carbon sources to culture, and the resulting extracellular polysaccharide peptide produces different monosaccharides. The composition of its extracellular polysaccharide peptide stimulates macrophages RAW264.7 to produce different amounts of nitric oxide and cytokines. SUMMARY OF THE INVENTION The inventors of the present invention collected different fruit bodies of Yunzhi from the Nantou mountainous area of Taiwan. After isolation and culture, one of the strains of Yunzhi strain LH-1 was found to grow rapidly and the mycelium yield was high. The preservation center identified its scientific name TVameies verhco/or (L.) Lloyd [species identification report, such as attached books], and found that it can produce novel extracellular polysaccharide peptide (ePSP-Cv), and the medium conditions used It has a higher product specific production rate and promotes the immunomodulatory activity of cytokine secretion of 201116623, wherein the cytokine is tumor necrosis factor-a (TNF-a). Adding a small amount of Scutellaria barbata L. (Sc) to the culture medium can significantly increase the ratio of the production rate of the extracellular polysaccharide peptide (ePSP-Cv-SBE) and the immunomodulatory biological activity. The activity comprises promoting macrophage proliferation, promoting the production of nitric oxide in macrophages and promoting the secretion of cytokines; wherein the cytokines are tumor necrosis factor-a (TNF_a), interleukin-ip (IL-lp) and interleukin素_6(IL_6). [Embodiment] Yunzhi (TVflw is a T TT1) is currently deposited in the Bioresource Conservation Center of the Food Industry Development Research Institute, and the registration number is BCRC930112. Scutellaria barbata extract (SBE, ) After adding water to the ratio, the extract of Scutellaria barbata L. will dry the Scutellaria barbata L. 1 (Semabet): 10 (water

將上清液減壓濃縮到體積為1 〇〇毫升, (SBE)。 畫^·^態培卷及胁.外多醣肽公離製借 到取上述保存之雲芝菌種,將其接種於培養基,在25。〇: 溫度下,於值溫震盈培養箱中以振盪速率⑽聊振盪培^ 天做為種菌。 其中該培養基之一實施配方如下: 培卷某配.古 201116623 成分 含量 葡萄糖(glucose) 4 蛋白腺(peptone) 0.3 磷酸二氫鉀(KH2P〇4) 0.15 硫酸鎂(MgS04 7H20) 0.15 分別以無添加半枝蓮萃取液(SBE)之上述培養基,或添 加0.5% (v/v)半枝蓮萃取液之上述培養基,以1〇%種菌接 鲁 種量’於20公升發酵槽中進行培養(溫度25°C ;攪拌速率 150 rpm ;通氣量1 vvm)。將培養7天後之醱酵培養液,以 6000 rpm離心30分鐘,可得菌絲體及上清液。將上清液經 四倍量的95 %酒精,澱析24小時後再經離心,沉澱之多醣 肽即為胞外多 II 肽(extracellular polysaccharopeptides, ePSP)。本發明中將培養基中無添加半枝蓮萃取物(SBE)培養 所得分離之雲芝胞外多醣肽稱為「雲芝胞外多醣肽 • (ePSP-Cv)」’培養基中添加半枝蓮萃取物(sbe)培養所得分離 之雲芝胞外多醣肽稱為「半枝蓮雲芝胞外多醣肽 (ePSP-Cv-SBE)」。 分折方法 结絲翰生皙量C biomass )測定 將醱酵培養液以6000 rpm離心30分鐘,可得菌絲體及 上清液。將菌絲體加入10 ml去離子水懸浮清洗,以6〇〇〇 rpm 201116623 離心30分鐘,重複三次。所得菌絲體冷凍乾燥後秤重,即 為菌絲體生質量。 胞外多醣肽測定The supernatant was concentrated under reduced pressure to a volume of 1 mL, (SBE). Draw the ^·^ state of the culture and the threat. The exopolypeptide peptide is transferred to the above-preserved Yunzhi strain and inoculated into the medium at 25. 〇: At the temperature, in the value of the temperature shock incubator, the oscillation rate (10) is used to oscillate and culture as an inoculum. One of the mediums is formulated as follows: a certain volume of the culture. Ancient 201116623 Ingredients glucose (glucose) 4 protein gland (peptone) 0.3 potassium dihydrogen phosphate (KH2P〇4) 0.15 magnesium sulfate (MgS04 7H20) 0.15 The above medium of Scutellariae Radix Extract (SBE), or the above-mentioned medium supplemented with 0.5% (v/v) Scutellariae Radix Extract, cultured in a 20 liter fermentation tank with 1% of the inoculum 25 ° C; agitation rate 150 rpm; aeration 1 vvm). The mycelium culture medium after 7 days of culture was centrifuged at 6000 rpm for 30 minutes to obtain mycelium and supernatant. The supernatant was subjected to four times the amount of 95% alcohol, and after 24 hours of precipitation, the precipitated polysaccharide peptide was extracellular polysaccharopeptides (ePSP). In the present invention, the isolated Yunzhi extracellular polysaccharide peptide obtained by adding the non-added Scutellaria barbata extract (SBE) in the culture medium is referred to as "the Yunzhi extracellular polysaccharide peptide (ePSP-Cv)" medium, and the addition of Scutellaria barbata L. extract is added. The isolated glutinous exopolysaccharide peptide obtained by culturing the sbe is called "semi-dragon yoghurt extracellular polysaccharide peptide (ePSP-Cv-SBE)". Folding method C biomass measurement The mycelium and supernatant were obtained by centrifuging the fermentation broth at 6000 rpm for 30 minutes. The mycelium was suspended in 10 ml of deionized water, and centrifuged at 6 rpm 201116623 for 30 minutes, three times. The obtained mycelium is freeze-dried and weighed, which is the mycelial body mass. Extracellular polysaccharide peptide assay

將醱酵培養液以6000 rpm離心30分鐘,可得菌絲體及 上清液。上清液加入四倍量的95%酒精,澱析24小時後再 經離心,沉澱物依據Dubois等人(1956 )「酚硫酸法 (phenol-sulphuric acid method)」及 AOAC 方法(1995)分析其 中含多醣及蛋白質組成,此一製備物為即為胞外多醣肽,將 此沉澱物冷凍乾燥後秤重。 丰枝篷多醣肽(PSP-SB)測定 將半枝蓮萃取液(SBE)以四倍量95%酒精沉澱24小時 後,離心分離所得之沉殿物,依據Dubois等人( 1956)「酌· 硫酸法(phenol-sulphuric acid method)」及 AOAC 方法(1995) 分析其中含多醣及蛋白質組成,此一製備物為半枝蓮多醣肽 (PSP-SB ),將此沉澱物冷凍乾燥後秤重。 統計分析 本發明中之實驗數據以Statistical Analysis System 6.0 軟體進行分析,以 ANOVA作變異分析,並以Duncan’s multiple range test做平均值顯著性差異之比較(p < 0.05)。 實施例一以丰枝蓮萃取液(SBE)促進雲窆胞外多醣肽(ePSP) 生產 雲芝菌株LH1接種於20公升發酵槽中,其中之培養基 201116623 有兩種:分別為添加及無添加(對照組)半枝蓮萃取液之培 養基。測量深層培養7天後所得之胞外多醣肽含量,結果如 表一所示。與對照組比較,經添加0.5%的半枝蓮萃取液(+SBE) 培養所得之半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)含量隨者 培養時間逐漸增加,經7天培養後產量可達到1.37 g/L,相 對於無添加半枝蓮萃取液之培養基(-SBE),雲芝胞外多醣肽 (ePSP-Cv)只得到0.61 g/L,產量顯著增加2.2倍。 本發明與文獻中不同雲芝品系與培養基對其胞外多醣 肽(ePSP)、菌絲體生質量及產物比生成率之比較如表一所 示。就產物比生成率之觀點,台灣本土雲芝LH1品系所產生 之雲芝胞外多醣肽(ePSP-Cv)之產物比生成率及半枝蓮雲芝 胞外多醣肽(ePSP-Cv-SBE)之產物比生成率分別為0.26及 0.38,皆較習知文獻中產物比生成率為高。 過去文獻中,雲芝菌株品系INETI培養於酵母麥芽培養 基中只能產生0.70 g/L胞外多酷肽(Tavares, Coelho,Agapito, Coutinho & Xavier, 2005);雲芝菌株品系 Wr-74 及 ATCC-20545,培養於添加乳清之培養基中能產生 1.15和 1 ·32 g/L 胞外多 _ 肽(Cui,Goh,Archer, & Singh, 2007),但產 量均較本發明之半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)產量 1.66 g/L 為低。 201116623 外多 菌絲 雲芝品系 添加物 醣狀 體生產物比 (g/L)質量生f率 參考文獻 LH1 LH1 ΙΝΕΤΙ Wr-74 ATCC20545 J& ***、 0.5%半枝 蓮萃取液 酵母麥芽萃 取物 乳清 乳清 0.61 1.37 0.70 2.38 3.70 3.8 0.26 0.38 0.18 ί 產物比生成率:胞外多醣狀/菌絲體生質. 本發明 本發明 Tavares et al (2005) Cui etal. (2007) Cui et al (2007) 本發明中半枝蓮萃取液(SBE)於培養基中之添加量為 0.5% (νΛ〇,亦即每毫升培養液中含有極微量半枝蓮萃取物 即可產生顯著增加半枝蓮雲芝胞外多醣肽(ePSp_Cv_SBE)產 量之效果。 利用A ◦ A C (1 9 9 5 )方法檢測半枝蓮萃取物之一般化學組 成’其碳水化合物佔38.10°/。、粗蛋白佔16 27%、粗脂肪佔 6.75%、灰分佔10.71°/。及粗纖維佔28.17%,顯示碳水化合物 為其主要化學組成。半枝蓮中含有黃芩素苷(scutellarin ”芽 菜 素(apigenin)、 木 犀草素(luteolin)、 E-1 -(4V-hydroxyphenyl)-but-l-en-3-one 、 原 兒茶酸 (protocatechuic acid) 、 acacetin-7-diglucuronide 及 luteolin-7-diglucuronide及其他黃酮類化合物等。微生物培 201116623 養基之成分在菌體生長及代謝物分泌過程扮演了重要角 色,半枝蓮萃取液之添加有益於菌絲生質量及ePSP生產可 能與其所含成分有關。 膏施例二雲芝胞外多醣肽(ePSP-Cv)、丰枝篷雲芝胞外多醣 肽(ePSP-Cv-SBE)及丰枝蓮多醣肽(PSP-SB)化 學特性 一、蛋白質含量 以AOAC方法(1995)分析之。 如表二所示,雲芝胞外多醣肽(ePSP-Cv)之蛋白質含量為 13.8 土 0·3%,半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)之蛋白 質含量為15.6 ± 0.3% ;半枝蓮多醣肽(PSP-SB )之蛋白質 含量為19.0 ± 0.7%。半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE) 之蛋白質含量為雲芝胞外多醣肽(ePSP-Cv)之1.13倍。 表二雲芝胞外多醣肽(ePSP-Cv)、枸杞雲芝胞外多醣肽(ePSP-Cv-SBE) 及枸杞多醣肽(PSP-SB)蛋白質含量比較 多醣肽 蛋白含量(%) 雲芝胞外多醣肽(ePSP-Cv) 13.8 ±0.3 半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE) 15.6 ±0.3 半枝蓮多醣肽(PSP.-SB) 19.0 ±0.7 二、單酷組成分析 以 5 毫升之 2M 三敗醋酸(trifluoroacetic acid,TFA )水 解多醣肽,於1 〇〇°C作用16小時。再以高效能液相層析儀 (HPLC,Jasco PU-2080 PLUS),以 SUGAR SP0810 管柱 11 201116623 (Shodex) (8mm x 3〇〇mm)分析中性單醣成分,其中該管棱 流速為。一 ’移動相為去離子水,管柱之溫二 本發明中雲芝胞外多聽狀之單畴含量經成與其他文 之比較’如表三所示,成分包含葡萄糖(glue。⑷半礼獻 (galactose) '甘露糖(mann〇se)、木糖㈣〇叫及阿拉=糠 (arabinose)。與Tavares ei αΜ2〇〇5)之文獻比較其雲笑掩 外多醣肽中單糖組成中未發現有半乳糖之存在,而本發明: 台灣本土雲芝LH1品系所產生之雲芝胞外㈣肽(柳心) 及半枝蓮雲芝胞外多st肽(ePSP_Cv_SBE)之單糖組成中則分 別3有8.67 mg/g及21.38 mg/g之半乳糖,顯然為—新型雲 芝胞外多醣肽。 表1 一 t發明中雲芝胞外乡酿之W含量喊與其他文獻之比較 單糖組成(mg/g ratio) 多醣肽 葡萄糖 半乳糖 甘露糖 木糖 阿拉伯糖 引用文獻 ePSP-Cv*1 82.27 8.67 8.18 0.87 η.ά*2 本發明 ePSP-Cv-SBE*3 60.64 21.38 6.66 7.43 3.89 本發明 ePSP-Cv-LBE*4 80.06 9.29 1.92 8.73 n.d. Lin et al., 2008 PSP-SB*5 10.78 71.00 15.45 n.d. n.d. 本發明 PSP-LB*6 49.21 17.06 n.d. 1.33 32.40 Lin et al., 2008The mycelium and the supernatant were obtained by centrifuging the fermentation broth at 6000 rpm for 30 minutes. The supernatant was added with four times the amount of 95% alcohol, and after 24 hours of precipitation, it was centrifuged, and the precipitate was analyzed according to Dubois et al. (1956) "Phenol-sulphuric acid method" and AOAC method (1995). Containing polysaccharide and protein composition, this preparation is an exopolysaccharide peptide, and the precipitate is freeze-dried and weighed. Determination of Polysaccharide Peptide (PSP-SB) of Fengzhitang Polysaccharide (PSP-SB) After the Scutellariae Radix Extract (SBE) was precipitated in four times the amount of 95% alcohol for 24 hours, the obtained sediment was separated by centrifugation according to Dubois et al. (1956). The phenol-sulphuric acid method and the AOAC method (1995) analyzed the composition of the polysaccharide and protein, and the preparation was a Scutellaria barbata polysaccharide peptide (PSP-SB), which was freeze-dried and weighed. Statistical Analysis The experimental data in the present invention were analyzed by Statistical Analysis System 6.0 software, analyzed by ANOVA, and Duncan's multiple range test was used to compare the significant differences (p < 0.05). Example 1 Promoting the Extracellular Polysaccharide Peptide (ePSP) of the Yunzhilian Extract (SBE) by the Fengzhilian Extract (SBE) The Yunzhi strain LH1 was inoculated into a 20-liter fermentation tank. There were two kinds of medium 201116623: added and not added ( Control medium) Medium of Scutellaria barbata extract. The extracellular polysaccharide peptide content obtained after 7 days of submerged culture was measured, and the results are shown in Table 1. Compared with the control group, the content of extracellular polysaccharide peptide (ePSP-Cv-SBE) obtained by adding 0.5% of Scutellaria barbata extract (+SBE) was gradually increased with the culture time, and cultured for 7 days. The yield was 1.37 g/L. Compared with the medium without added Scutellaria barbata extract (-SBE), the Yunzhi extracellular polysaccharide peptide (ePSP-Cv) only obtained 0.61 g/L, and the yield increased significantly by 2.2 times. The comparison between the present invention and the literature in the different strains of Yunzhi strain and medium for its extracellular polysaccharide peptide (ePSP), mycelium biomass and product ratio is shown in Table 1. From the point of view of the ratio of product to production, the ratio of the product ratio of the exopolysaccharide peptide (ePSP-Cv) produced by the LH1 strain of Taiwan native Yunzhi LH1 strain and the extracellular polysaccharide peptide of echinacea (ePSP-Cv-SBE) The product specific ratios were 0.26 and 0.38, respectively, which were higher than the product ratio in the prior art. In the past literature, the Yunzhi strain strain INETI was cultured in yeast malt medium and produced only 0.70 g/L extracellular peptide (Tavares, Coelho, Agapito, Coutinho & Xavier, 2005); Yunzhi strain Wr-74 And ATCC-20545, cultured in whey-added medium to produce 1.15 and 1 · 32 g / L extracellular poly-peptide (Cui, Goh, Archer, & Singh, 2007), but the yield is half of the present invention The yield of the extracellular polysaccharide peptide (ePSP-Cv-SBE) of Zhizhiyunzhi was low at 1.66 g/L. 201116623 Exopolymycetes, Ganoderma lucidum, Additives, Glycogen production ratio (g/L), Quality, F rate, Reference LH1 LH1 ΙΝΕΤΙ Wr-74 ATCC20545 J& ***, 0.5% Scutellaria bark extract yeast malt Extract Whey Whey 0.61 1.37 0.70 2.38 3.70 3.8 0.26 0.38 0.18 ί Product ratio generation rate: extracellular polysaccharide/mycelium biomass. The present invention is Tavares et al (2005) Cui et al. (2007) Cui et Al (2007) In the present invention, the addition amount of Scutellaria barbata extract (SBE) in the medium is 0.5% (vΛ〇, that is, a trace amount of Scutellaria barbata extract per ml of the culture solution can produce a significant increase in half-branched The effect of the production of extracellular polysaccharide peptide (ePSp_Cv_SBE) was studied. The general chemical composition of Scutellaria barbata extract was determined by A ◦ AC (1 9 9 5) method, which accounted for 38.10°/carbohydrate and 1627 crude protein. %, crude fat accounted for 6.75%, ash accounted for 10.71 ° /. and crude fiber accounted for 28.17%, indicating that carbohydrate is its main chemical composition. Scutellaria barbata contains scutellarin (apigenin), hibiscus Luteolin, E-1 -(4V-hydroxyphenyl)-bu Tl-en-3-one, protocatechuic acid, acacetin-7-diglucuronide and luteolin-7-diglucuronide and other flavonoids, etc. Microbial culture 201116623 Nutrient components in cell growth and metabolite secretion The process plays an important role. The addition of Scutellaria barbata L. extract is beneficial to the quality of mycelium and the production of ePSP may be related to its components. Paste application 2 Yunzhi extracellular polysaccharide peptide (ePSP-Cv), Fengzhi canopy Yunzhi Chemical characteristics of extracellular polysaccharide peptide (ePSP-Cv-SBE) and polysaccharides of Fengzhilian (PSP-SB) 1. Protein content was analyzed by AOAC method (1995). As shown in Table 2, Yunzhi extracellular polysaccharide peptide ( The protein content of ePSP-Cv) was 13.8 ± 0.3%, and the protein content of the extracellular polysaccharide peptide (ePSP-Cv-SBE) was 15.6 ± 0.3%; Scutellaria barbata polysaccharide peptide (PSP-SB) The protein content was 19.0 ± 0.7%. The protein content of the extracellular polysaccharide peptide (ePSP-Cv-SBE) was 0.13 times that of the Yunzhi extracellular polysaccharide peptide (ePSP-Cv). Polysaccharide peptide (ePSP-Cv), 枸杞云芝 extracellular polysaccharide peptide (ePSP-Cv-SBE) and 枸杞 polysaccharide peptide (PSP-SB) egg Comparison of polysaccharide content of polysaccharide peptide protein (%) Yunzhi extracellular polysaccharide peptide (ePSP-Cv) 13.8 ±0.3 Scutellaria barbata exopolysaccharide peptide (ePSP-Cv-SBE) 15.6 ±0.3 Scutellaria barbata polysaccharide peptide (PSP) .-SB) 19.0 ±0.7 2. Single Cool Composition Analysis The polysaccharide peptide was hydrolyzed with 5 ml of 2 M trifluoroacetic acid (TFA) and allowed to act at 1 ° C for 16 hours. The neutral monosaccharide composition was analyzed by high performance liquid chromatography (HPLC, Jasco PU-2080 PLUS) with SUGAR SP0810 column 11 201116623 (Shodex) (8mm x 3〇〇mm), wherein the tube flow rate was . A 'moving phase is deionized water, the temperature of the column is two. The single domain content of the extracellular auditory form of Yunzhi in the invention is compared with other texts. As shown in Table 3, the composition contains glucose (glue. (4) half Galactose 'mannosese', xyloose (four) squeaking and arabinose. Compared with the literature of Tavares ei αΜ2〇〇5), the composition of monosaccharides in the polysaccharides of Yunxiao No galactose was found, and the present invention: the monosaccharide composition of the extracellular (tetra) peptide (Liu Xin) and the extracellular st peptide (ePSP_Cv_SBE) of the Yunzhi extracellular (tetraploid) produced by the native L. sylvestris LH1 strain in Taiwan Then there are 8.67 mg/g and 21.38 mg/g galactose, respectively, which is obviously the new type of Yunzhi extracellular polysaccharide peptide. Table 1 In the invention, the W content of Yunzhi extracellular township shouted compared with other literatures. Monosaccharide composition (mg/g ratio) Polysaccharide peptide Glucosamine galactose Xylose arabinose References ePSP-Cv*1 82.27 8.67 8.18 0.87 η.ά*2 The present invention ePSP-Cv-SBE*3 60.64 21.38 6.66 7.43 3.89 The present invention ePSP-Cv-LBE*4 80.06 9.29 1.92 8.73 nd Lin et al., 2008 PSP-SB*5 10.78 71.00 15.45 ndnd Invention PSP-LB*6 49.21 17.06 nd 1.33 32.40 Lin et al., 2008

12 201116623 y無添加中藥萃取液所得之雲芝胞外多醣肽 *2n.d.未偵測到 *3添加半枝蓮萃取液所得之雲芝胞外多醣肽 *4添加枸杞萃取液所得之雲芝胞外多醣肽 *5半枝蓮多醣肽 *6枸杞多醣肽 比較半枝蓮多醣肽(PSP-SB)、雲芝胞外多醣肽(ePSP-Cv) 及半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE),其中半枝蓮多醣 肽含有較多的半乳糖(71.00 mg/g)及甘露糖(15.45 mg/g),且 無檢測出木糖及阿拉伯糖。然而,經過7天發酵培養後’於 雲芝半枝蓮胞外多醣肽中檢測到阿拉伯糖(3.89 mg/g),表示 半枝蓮萃取液(SBE)中之半枝蓮多醣肽(PSP-SB)’在發酵過程 中已被使用且轉化成不同之單醣。 比較雲芝胞外多醣肽(ePSP-Cv)及半枝蓮雲芝胞外多醣 肽(ePSP-Cv-SBE),半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)之 葡萄糖含量(60.64%)遠低於雲芝胞外多醣肽(ePSP-Cv)葡萄 糖含量(82.27%),而半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE) • ' 之半乳糖含量(21.38%)遠高於雲芝胞外多醣肽(ePSP-Cv)半 乳糖含量(8.67%),同時半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE) 之木糖含量(7.43%)遠高於雲芝胞外多醣肽(ePSP-Cv)木糖 含量(0.87%),但該兩組之胞外多醣肽所含之甘露糖含量,基 本上是接近的,介於約為6.66-8.18%。顯示微量半枝蓮萃取 液添加於雲芝醱酵培養基中,不僅有助於其胞外多醣肽產量 之大幅提升,對於其胞外多醣肽之化學組成及單糖含量亦有 13 201116623 明顯之影響。12 201116623 y Yunzhi extracellular polysaccharide peptide obtained from the Chinese herbal extract without extracting *2n.d. The cloud obtained from the addition of the scutellaria extract of the Yunzhi extract of the Scutellaria barbata extract*4 Comparison of the extracellular polysaccharide peptide *5 Scutellaria barbata polysaccharide peptide *6 枸杞 polysaccharide peptide compared to Scutellaria barbata polysaccharide peptide (PSP-SB), Yunzhi extracellular polysaccharide peptide (ePSP-Cv) and Scutellaria barbata exopolysaccharide peptide (ePSP-Cv-SBE), in which the Scutellaria barbata polysaccharide peptide contained more galactose (71.00 mg/g) and mannose (15.45 mg/g), and no xylose and arabinose were detected. However, after 7 days of fermentation, 'arabinose (3.89 mg/g) was detected in the extracellular polysaccharide peptide of Radix Paeoniae Alba, indicating the Scutellaria barbata polysaccharide peptide (SSP-) in Scutellaria barbata extract (SBE). SB) 'has been used in the fermentation process and converted into different monosaccharides. Comparison of the glucose content of the extracellular polysaccharide peptide (ePSP-Cv) and the extracellular polysaccharide peptide (ePSP-Cv-SBE), and the extracellular polysaccharide peptide (ePSP-Cv-SBE) of S. 60.64%) is far lower than the glucose content of Yunzhi extracellular polysaccharide peptide (ePSP-Cv) (82.27%), while the galactose content of echinacea extracellular polysaccharide peptide (ePSP-Cv-SBE) • '21.38% It is much higher than the galactose content (8.67%) of the extracellular polysaccharide peptide (ePSP-Cv) of Yunzhi, and the xylose content (7.43%) of the extracellular polysaccharide peptide (ePSP-Cv-SBE) of S. Yuyunzhi extracellular polysaccharide peptide (ePSP-Cv) xylose content (0.87%), but the mannose content of the exopolysaccharide peptides of the two groups is basically close, ranging from about 6.66-8.18%. . It is shown that the addition of trace amount of Scutellaria barbata L. extract to Yunzhi fermentation medium not only contributes to the substantial increase of the production of extracellular polysaccharide peptide, but also has obvious influence on the chemical composition and monosaccharide content of its extracellular polysaccharide peptide. .

Tavares ei <2/. (2 005)之文獻中,利用兩種不同培養基: 兹完全培養基(mushroom complete medium)及酵母麥芽萃取 物(yeast malt extract)培養棊培養雲芝菌INETI品系,亦顯 示培養基之組成差異會改變其所產生之胞外多醣肽中甘露 糖與木糖之含量。 三、多醣肽之傅氏紅外線光譜分析 以傅氏紅外線光譜儀試驗(Fourier Transform Infrared, FTIR)檢測其官能基,將樣品與KBr粉末於真空烘箱乾燥24 小時,混合均勻後(1:100)打成錠片,以傅立葉紅外線光譜儀 測試,其波數範圍由500〜4000 cnT1,解析度設定2 cm·1之 圖譜。In the literature of Tavares ei <2/. (2 005), two different media were used: culture complete medium and yeast malt extract to cultivate the INETI strain of Yunzhi bacteria. It is shown that the difference in composition of the medium changes the content of mannose and xylose in the extracellular polysaccharide peptide produced therefrom. 3. Fourier Infrared Spectroscopy Analysis of Polysaccharide Peptides The functional groups were detected by Fourier Transform Infrared (FTIR). The samples were dried in a vacuum oven for 24 hours with a KBr powder. After mixing evenly (1:100), The tablets were tested by a Fourier infrared spectrometer with a wavenumber ranging from 500 to 4000 cnT1 and a resolution of 2 cm·1.

利用 FTIR 分析 ePSP-Cv 和 ePSP-Cv-SBE 發現在 3419、 1641及1078 cm_1位置有明顯之吸收波峰(如圖一),Ng及 Chan提雲芝PSP的FTIR圖譜中有一波峰在1078 cm·1位置, Yang及Zhou指出雲芝PSP的FTIR圖譜中在3400、 1650、 1050 及 893 cm·1 各代表-OH·' -NH2、C-O-C 及 β-glycosidic 等官能基鍵結。在930、1038、1078及1161 cm·1位置亦表 現出有β-glycosidic等官能基鍵結。本實驗中三種多酶肽之 吸收波峰中雖無893 cnT1位置,但有1078 cm·1位置可說明 具有β(1—3)glycosidic官能基之鍵結。Yang及Zhang報告 14 201116623 中指出 905-876cm-l>ifr®t±7 女 βτΛ 1 ^ 丄 1位置中有β-D-glucose之吸收波峰,在 1100-1010 cm範圍pyranoside有三個強烈吸收峰, furanoside有二個吸收峰,本研究於11〇〇 i〇i〇 範圍亦 顯不有明m峰出現。Mata等分析甜菜實驗以FTIR之資 料亦說明1146 cm·1位置上有glyc〇sidic鍵結存在。Rau等 研究報導中指出C. veriico/π ATCC 2〇08〇1之胞外多醣肽中 含有以β(1—3)為主鏈連結葡萄糖,而在Q側鏈以β(1—6) 連結另一葡萄糖,說明胞外多醣肽同樣具有生物活性之 β(1—3)鍵結之結構。 綜合上述雲芝胞外多醣肽(ePSP_Cv)、半枝蓮雲芝胞外多 _狀(ePSP-Cv-SBE)及半枝蓮多醣肽(psp-SB)化學特性分 析與文獻之比較討論’顯示本發明中台灣本土雲芝Lh 1品系 添加半枝蓮萃取液所.產生之雲芝胞外多醣肽 (ePSP-Cv-SBE),使其胞外多醣肽產量增加’也使其化學組 成蛋白質含量及單醣組成分改變,而PSP_ SB、ePSP-Cv和 ePSP-Cv-SBE這三種多醣肽均具有β(1 —3)葡聚醣之生物活 性結構。比較本發明中雲芝胞外多醣肽(ePSP-Cv)及半枝蓮雲 芝胞外多醣肽(ePSP-Cv-SBE),兩者在蛋白質含量及單糖乡且 成含量亦有所不同。 童施例三雲芗敝外多醣肽(ePSP-Cv)、半枝蓮雲芝臉外年腹 肽(ePSP-Cv-SBE、及丰枝蓮多醣肽( 對巨噬細胞增生之影響 15 201116623 一、 巨噬細胞RAW 264.7培卷及多醣肽處理 將老鼠巨噬細胞RAW264.7 (ATCC TIB-71)培養於添加 10%胎牛血清、100 units/ml青黴素及1〇〇 g/ml鏈黴素之 Dulbecco’s Modified Eagle Medium (DMEM)培養基(Gibco 公司)中, 置於含有5%二氧化碳、37°C的細胞培養箱中培養,培養24 小時後,以2χ 105 cells/ml細胞密度進行試驗,分別加入濃 度為25 0 pg/mL的三種多醣肽:雲芝胞外多醣肽(epsP-Cv)、 φ 半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)及半枝蓮多醣肽 (PSP-SB)於 DMEM 培養‘中。 二、 多醣肽對巨噬細胞之影響 以MTT測試法分析老鼠巨噬細胞RAW264.7之細胞存活 及增生率,MTT測試法是測量存活細胞之粒線體内去氫酵素 (dehydrogenase)活性,用以間接測定細胞存活及增生率,該 方法為將細胞種於96孔盤中’使每孔之細胞密度為ΐχ 1〇4 • cells/100 μΐ/well,再分別添加最終濃度為62.5 pg/ml之多醣 肽ePSP-Cv、ePSP-Cv-SBE或PSP-SB溶液於細胞中,培養 48小時後,再加入30 pL MTT於C〇2培養箱(37°C)中培養2 小時,去除上清液再加入DMSO,以ELISA reader (Bio-Tek, pQuantTM^j其570 nm之吸光值。未加藥物組之〇.d值為基 本對照組(100%)。 結果顯示巨嗟細胞RAW 264.7添加入62.5 pg/mL的 16 201116623 ePSP-Cv、ePSP-Cv-SBE 和 PSP-SB,經 48 小時培養後相對 細胞生長率為1〇1.3土14_0、130.3±11.9及120.6士17.0%,統計 分析顯示此三種萃取物對巨噬細胞存活沒有顯著影響,如圖 二所示。 . f施例四雲窆胞外多醣肽(ePSP-Cv)、丰枝蓮雲芝胞外多醣 肽(ePSP-Cv-SBE)及丰枝蓮多醣肽(PSP-SB ) 對誘導巨噬細胞產生一氧化氮之影響 將巨噬細胞種於96孔盤中,使每孔之細胞密度為1 X 104Using FTIR to analyze ePSP-Cv and ePSP-Cv-SBE, it was found that there were obvious absorption peaks at 3419, 1641 and 1078 cm_1 (Fig. 1), and there was a peak in the FTIR spectrum of Ng and Chan T. yunzhi PSP at 1078 cm·1. Position, Yang and Zhou pointed out that the FTIR spectra of Yunzhi PSP represent functional groups such as -OH·' -NH2, COC and β-glycosidic at 3400, 1650, 1050 and 893 cm·1. Functional groups such as β-glycosidic are also shown at positions 930, 1038, 1078 and 1161 cm·1. In this experiment, although there are no 893 cnT1 positions in the absorption peaks of the three multi-enzyme peptides, the position of 1078 cm·1 indicates that there is a bond of β(1 -3)glycosidic functional groups. Yang and Zhang report 14 201116623 pointed out that 905-876cm-l>ifr®t±7 female βτΛ 1 ^ 丄1 has absorption peaks of β-D-glucose, and there are three strong absorption peaks in pyronoside in the range of 1100-1010 cm. There are two absorption peaks in furanoside. In this study, there is no obvious m peak in the range of 11〇〇i〇i〇. Mata et al. analyzed the sugar beet experiment with FTIR and indicated that there was a glycic sidic bond at 1146 cm·1. Rau et al. reported that the extracellular polysaccharide peptide of C. veriico/π ATCC 2〇08〇1 contains β(1-3) as the main chain linking glucose, while the Q side chain is linked by β(1-6). Another glucose, indicating that the exopolysaccharide peptide also has a biologically active β(1-3)-bonded structure. A comprehensive analysis of the chemical characteristics of the above-mentioned Yunzhi extracellular polysaccharide peptide (ePSP_Cv), extracellular phage (ePSP-Cv-SBE) and Scutellaria barbata polysaccharide (psp-SB) and the literature In the present invention, the native Japanese genus Yunzhi Lh 1 strain is added with the Scutellaria barbata extract (ePSP-Cv-SBE) to increase the production of extracellular polysaccharide peptide, which also makes its chemical composition protein content. And the composition of the monosaccharide is changed, and the three polysaccharide peptides of PSP_SB, ePSP-Cv and ePSP-Cv-SBE have the biologically active structure of β(1 -3) glucan. In comparison with the present invention, the Yunzhi extracellular polysaccharide peptide (ePSP-Cv) and the Scutellaria barbata exopolysaccharide peptide (ePSP-Cv-SBE) have different protein content and monosaccharide content. Children's application of Sanyun glutinous polysaccharide peptide (ePSP-Cv), Scutellaria barbata var. sinensis (ePSP-Cv-SBE, and Fengzhilian polysaccharide peptide (effect on macrophage proliferation 15 201116623) Macrophage RAW 264.7 culture and polysaccharide peptide treatment Mouse macrophage RAW264.7 (ATCC TIB-71) was cultured with 10% fetal bovine serum, 100 units/ml penicillin and 1〇〇g/ml streptomycin. Dulbecco's Modified Eagle Medium (DMEM) medium (Gibco) was cultured in a cell culture chamber containing 5% carbon dioxide at 37 ° C. After 24 hours of culture, the cells were tested at a cell density of 2 χ 105 cells/ml and added to the concentration. Three polysaccharide peptides at 25 0 pg/mL: Yunzhi extracellular polysaccharide peptide (epsP-Cv), φ Scutellaria yunnanensis extracellular polysaccharide peptide (ePSP-Cv-SBE) and Scutellaria barbata polysaccharide peptide (PSP-SB) In the culture of DMEM. II. Effect of polysaccharide peptide on macrophages The cell survival and proliferation rate of mouse macrophage RAW264.7 was analyzed by MTT assay. The MTT assay was used to measure the dehydrogenation of mitochondria in viable cells. Dehydrogenase activity for indirect determination of cell survival and proliferation rate, the method In order to seed the cells in a 96-well plate, the cell density of each well was ΐχ 1〇4 • cells/100 μΐ/well, and the final concentration of the polysaccharide peptides ePSP-Cv and ePSP-Cv- at a concentration of 62.5 pg/ml were added. SBE or PSP-SB solution was cultured in cells for 48 hours, then added with 30 pL of MTT in a C〇2 incubator (37 ° C) for 2 hours. The supernatant was removed and DMSO was added to ELISA reader (Bio- Tek, pQuantTM^j its absorbance at 570 nm. The 〇.d value of the untreated group was the basic control group (100%). The results showed that mega 264.7 was added to 62.5 pg/mL of 16 201116623 ePSP-Cv, The relative cell growth rates of ePSP-Cv-SBE and PSP-SB after 48 hours of culture were 1〇1.3 soil 14_0, 130.3±11.9 and 120.6±17.0%. Statistical analysis showed that these three extracts had no significant effect on macrophage survival. , as shown in Figure 2. f Example: Four-spotted extracellular polysaccharide peptide (ePSP-Cv), Fengzhilian Yunzhi extracellular polysaccharide peptide (ePSP-Cv-SBE) and Fengzhilian polysaccharide peptide (PSP-SB Effects of inducing nitric oxide production on macrophages. Macrophages are seeded in 96-well plates to a cell density of 1 X 104 per well.

cells。每孔中分別加入50μ1不同之多醣肽(最終濃度為 62.5pg/ml)後,再加入過遽後溶於DMEM之4pg/ml之50μ1 脂多糖(LPS)或同體積之培養基。48小時培養後,培養基中 一氧化氮之含量係以Greiss反應分析之,取出細胞之上清液 加入 96孔盤中,再加入等量的 Greiss 試劑(1°/〇 sulfanilamide、0.1% NED 及 5% H3P〇4)和 RNI,於室溫反 應15分鐘,以ELISA reader讀OD540 nm的吸光值。產生 之一氧化氮產量以硝酸納(sodium nitrite)製作標準曲線來對 照定量。 結果如圖三所示,於無添加 lpg/ml LPS時(-LPS), ePSP-Cv與對照組無顯著差異,而添加ePSP-Cv-SBE及 PSP-SB可誘導巨噬細胞產生大量的一氧化氮。添加LPS時 ( + LPS),添加ePSP-Cv及ePSP-Cv-SBE與對照組間並無明顯 差異,但添加PSP-SB卻有較少NO的產量。 巨噬細胞產生一氧化氮被認為是細胞的一種防禦功 17 201116623 能,一般係以LP S刺激細胞產生一氧化氮’作為一種檢測免 疫調節活性之方式。Wasser (2005)於研究中指出真菌含有 β( 1—3)葡聚醣多醣體可活化巨噬細胞,並促使巨噬細胞產生 一氧化氮,而一氧化氮於許多生物免疫反應中是很重要化學 傳遞物質。Pang等(1998)利用老鼠腹腔巨噬細胞經添加LPS 及PSK(為一種來自C. 菌株CM-101品系之多_ 肽)後,可產生一氧化氮。Wang等(1996)研究中指出經LPS 處理後C5 7BL/6老鼠也會誘導一氧化氮之產生,但若餵食來 自 C. verhco/or菌株Cov-1品系所產生之胞外及胞内多§1 肽,會被刺激產生更高量之一氧化氮。 於本實施例中,未添加LPS(-LPS)時,半枝蓮雲芝胞外 多醣肽(ePSP-Cv-SBE)即可促使巨噬細胞產生高達3.20 μΜ 之一氧化氮量,比對照組0.24 μΜ,或添加LPS(+LPS)時多 醣肽組之平均值2.5 9 μΜ所產生之一氧化氮量為高,顯示半 枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)為一相當具有應用潛力 之免疫調節劑。 實施例五雪窆胞外多醣肽(ePSP-Cv)、半枝蓮雲芝胞外多醣 肽(ePSP-Cv-SBE)及丰枝蓮多醣肽(PSP-SB ) 讀導巨噬細胞產生細胞激素之分析 將細胞種於 24孔盤中,使每孔細胞濃度為 105 cells/5 00p卜分別加入250μ1多醣肽及250μ1 LPS或同體積之 培養基,使每孔的最終體積達到lm卜最終濃度為62.5pg/ml 之多醣肽。放入細胞培養箱(5% C02,3 7。〇中培養48小 18 201116623 時’收集細胞上清液,冷凍於-80°C以便進行細胞激素分泌 的測定分析。以商業化細胞激素ELISA套組測定培養上清液 的細胞激素濃度。採用小鼠介白素·ip (m〇use iL ip, e-Bioscience)、小鼠介白素-6 (mouse IL_6, e_Bi〇science),小 鼠腫瘤壞死因子 _a(TNF-a) (mouse TNF-α, e-Bioscience)商業 化套组來定量之。 於巨噬細胞RAW 264.7培養基中,分別添加雲芝胞外多 • 醣肽(ePSP_Cv)、半枝蓮雲芝胞外多醣肽(ePSP-Cv-SBE)及半 枝蓮多醣肽(PSP-SB ),於有/無添加LPS之處理後,探討前 述三種細胞激素分泌量。三種多醣肽對於巨噬細胞產生 TNF-a之影響如圖四所示’結果顯示未添加Lps時(_Lps), 該三種多醣肽相對於對照組,均能顯著刺激巨噬細胞產生 4-5倍之TNF-a量;但若添加LPS時(+Lps),無論是有/無添 加多醣肽之細胞’均會顯著增加TNF_a量,且彼此間並無顯 # 著差異。 二種多醣肽對於巨噬細胞產生IL_ip之影響如圖五所 示,與對照組比較,該三種多醣肽亦均能刺激巨噬細胞產生 IL-Ιβ。於未添加LPS時(_Lps),添加半枝蓮雲芝胞外多醣肽 (ePSP-Cv-SBE)及半枝蓮多醣肽(psp_SB)可促使巨噬細胞 產生IL-Ιβ’其中半枝蓮雲芝胞外多醣肽(epSp-CvSBE)具有 非常顯著提高巨噬細胞IL_ip之生物活性;若添加Lps時 ( + LPS) ’半枝蓮雲芝胞外多·醣肽(ePSP-Cv-SBE)及半枝蓮多 201116623 聽肽(PSP-SB )亦可促使巨嗟細胞產生iL-1 β,但彼此間並 無顯著差異* 有無添加半枝蓮萃取液於培養基中所產生雲芝胞外多 醣肽及半枝蓮多醣肽於有無添加脂多醣(LPS)對巨噬細胞 RAW 264.7產生細胞激素IL-6產量之影響如圖六所示,結果 顯示巨嗤細胞RAW 264.7添加ePSP-Cv-SBE和PSP-SB,明 顯增加IL-6產量,與對照組比較增加19 5及7.〇倍。 PSP於體外研究模式以巨嗟細胞或其他白血球促進白細 胞介素能力之探討廣泛使用於免疫調節活性上。在本案中 ePSP-Cv-SBE可使巨噬細胞增加TNF-α、IL-Ιβ及il-6細胞 激素之分泌量。TNF-a及ΙίΛΙβ對癌細胞有毒殺之效果及活 化Τ淋巴細胞之作用。Mtiller及Meineke指出細胞激素相互 間關係,TNF-a及IL-Ιβ會誘導IL-6合成,而iL-6又會抑 制TNF-a及IL-Ιβ,此三種細胞激素在免疫調節上扮演重要 角色。Cui等人利用乳清作為雲芝培養基之添加物所得到之 胞外及胞内多醣亦有類似的免疫調節活性。同時先前研究添 加枸杞萃取液於雲芝培養基中所得之多醣肽也可增加 IL-Ιβ、IL-6及TNF-a之活性,顯示PSPs誘導巨噬細胞所產 生免疫活性與其不同之化學組成可能有密切關係,亦即其組 成分之差異會造成對RAW264 7細胞產生不同分泌量之激 素0Cells. 50 μl of different polysaccharide peptides (final concentration of 62.5 pg/ml) were added to each well, and then 4 μg/ml of 50 μl lipopolysaccharide (LPS) or the same volume of medium dissolved in DMEM was added. After 48 hours of incubation, the content of nitric oxide in the medium was analyzed by Greiss reaction. The supernatant from the cells was removed and added to a 96-well plate, and an equal amount of Greiss reagent (1°/〇sulfanilamide, 0.1% NED and 5) was added. % H3P〇4) and RNI were reacted at room temperature for 15 minutes, and the absorbance at OD540 nm was read by an ELISA reader. One of the nitrogen oxide production yields is measured by a standard curve made of sodium nitrite. The results are shown in Figure 3. When no lpg/ml LPS was added (-LPS), ePSP-Cv was not significantly different from the control group, and the addition of ePSP-Cv-SBE and PSP-SB induced a large number of macrophages. Nitric oxide. When LPS was added (+ LPS), there was no significant difference between the addition of ePSP-Cv and ePSP-Cv-SBE and the control group, but the addition of PSP-SB had less NO production. The production of nitric oxide by macrophages is considered to be a defensive work of cells. 17 201116623 Yes, it is common to use LPS to stimulate cells to produce nitric oxide as a means of detecting immunomodulatory activity. Wasser (2005) pointed out in the study that fungi contain β(1-3) glucan polysaccharides that activate macrophages and promote macrophages to produce nitric oxide, which is important in many biological immune responses. Chemical delivery of substances. Pang et al. (1998) produced nitric oxide using mouse peritoneal macrophages by the addition of LPS and PSK (a polypeptide derived from the C. strain CM-101 strain). Wang et al (1996) pointed out that C5 7BL/6 mice also induced nitric oxide production after LPS treatment, but extracellular and intracellular production if fed from C. verhco/or strain Cov-1 strain A peptide that is stimulated to produce a higher amount of one of the nitrogen oxides. In this example, when LPS (-LPS) is not added, the scutellaria sylvestris extracellular polysaccharide peptide (ePSP-Cv-SBE) can promote macrophage production of up to 3.20 μΜ of one of the nitrogen oxides, compared with the control group. 0.24 μΜ, or the addition of LPS (+LPS), the average value of the polysaccharide peptide group of 2.5 9 μΜ produced a high amount of nitrogen oxide, indicating that the S. cerevisiae extracellular polysaccharide peptide (ePSP-Cv-SBE) is equivalent. An immunomodulator with potential for application. Example 5: Xueyan extracellular polysaccharide peptide (ePSP-Cv), Scutellaria barbata exopolysaccharide peptide (ePSP-Cv-SBE) and Fengzhilian polysaccharide peptide (PSP-SB) read macrophages to produce cytokines The cells were seeded in 24-well plates, and the cell concentration of each cell was 105 cells/5 00p. 250μ1 polysaccharide peptide and 250μ1 LPS or the same volume of medium were added to make the final volume of each well reach the final concentration of 62.5. Pg/ml polysaccharide peptide. Place the cell supernatant in a cell culture incubator (5% C02, 3 7. Culture medium 48 small 18 201116623), freeze at -80 °C for analysis of cytokine secretion assay. Commercialized cytokine ELISA kit The cytokine concentration of the culture supernatant was determined by using a mouse interleukin ip (m〇use iL ip, e-Bioscience), mouse interleukin-6 (mouse IL_6, e_Bi〇science), mouse tumor Necrosis factor-a (TNF-a) (mouse TNF-α, e-Bioscience) was quantified by commercialization. In the macrophage RAW 264.7 medium, Yunzhi extracellular poly-glycopeptide (ePSP_Cv) was added. Exopolysaccharide peptide (ePSP-Cv-SBE) and Scutellaria barbata polysaccharide (PSP-SB) were studied in the presence or absence of LPS, and the three cytokine secretions were investigated. The effect of macrophage production of TNF-a is shown in Figure 4. 'The results show that when Lps is not added (_Lps), the three polysaccharide peptides can significantly stimulate macrophages to produce 4-5 times of TNF-a relative to the control group. Amount; however, if LPS is added (+Lps), both cells with or without added polysaccharide peptide will significantly increase TNF _a amount, and there is no significant difference between them. The effect of two polysaccharide peptides on the production of IL_ip by macrophages is shown in Figure 5. Compared with the control group, the three polysaccharide peptides can also stimulate the production of IL by macrophages. Ιβ. When LPS is not added (_Lps), the addition of S. cerevisiae extracellular polysaccharide peptide (ePSP-Cv-SBE) and Scutellaria barbata polysaccharide peptide (psp_SB) can promote macrophage production of IL-Ιβ' The extracellular polysaccharide peptide (epSp-CvSBE) of Lianyunzhi has a very significant increase in the biological activity of IL_ip in macrophages; if Lps is added (+ LPS), the extracellular glycopeptide (ePSP-Cv-SBE) ) and Scutellaria barbata 201116623 Peptide (PSP-SB) can also induce iL-1 β in giant sputum cells, but there is no significant difference between them * There is no addition of Scutellaria barbata extract in the medium to produce extracellular The effect of polysaccharide peptide and Scutellaria barbata polysaccharide peptide on the production of cytokine IL-6 produced by macrophage RAW 264.7 in the presence or absence of lipopolysaccharide (LPS) showed that 嗤 264.7 was added to ePSP-Cv-SBE. And PSP-SB, significantly increased IL-6 production, compared with the control group increased by 19 5 and 7. 〇 times. PSP in vivo The study model is widely used in the immunomodulatory activity of megatuber cells or other white blood cells to promote interleukin ability. In this case, ePSP-Cv-SBE can increase macrophages to increase TNF-α, IL-Ιβ and il-6 cells. The amount of hormone secreted. TNF-a and ΙίΛΙβ have a toxic effect on cancer cells and activating sputum lymphocytes. Mtiller and Meineke pointed out that cytokines are related to each other. TNF-a and IL-Ιβ induce IL-6 synthesis, while iL-6 inhibits TNF-a and IL-Ιβ. These three cytokines play an important role in immune regulation. . Extracellular and intracellular polysaccharides obtained by Cui et al. using whey as an additive to Yunzhi medium also have similar immunomodulatory activities. At the same time, the polysaccharide peptide obtained by adding the sputum extract to Yunzhi medium can also increase the activity of IL-Ιβ, IL-6 and TNF-a, indicating that the immunological activity of PSPs induced by macrophages and their different chemical compositions may be Close relationship, that is, the difference in its composition will cause hormones that produce different secretions to RAW264 7 cells.

20 201116623 【參考文獻】 •王志遠、戴玲、張凱(民97),半枝蓮多醣的提取純化及抗氧化活性研 究, 中國生化藥物雜誌,29(2),96-103。 2·王峰、丁重陽、王玉紅、章克昌(民94),九味中藥對雞腿蘑深層發酵 的影響’食品科學,26 (10),144-146。 3·仲浩’薛曉霞’姚慶强(民97)·,半枝蓮化學成分的研究,中草藥,3 ⑴,21-23。20 201116623 [References] • Wang Zhiyuan, Dai Ling, Zhang Kai (Min 97), Extraction, Purification and Antioxidant Activity of Polysaccharide from Scutellaria Barbata L., Chinese Journal of Biochemical Drugs, 29(2), 96-103. 2. Wang Feng, Ding Chongyang, Wang Yuhong, Zhang Kechang (Min 94), Effects of Jiwei Chinese Medicine on Deep Fermentation of Coprinus comatus. Food Science, 26 (10), 144-146. 3. Zhong Hao 'Xue Xiaoxia' Yao Qingqiang (Min 97) · Research on the chemical constituents of Scutellaria barbata L., Chinese herbal medicine, 3 (1), 21-23.

4. 林敬明、劉煌、羅榮城(民95) ’半枝蓮的化學成分及其抗腫瘤作用的研 究現狀,中藥材,29 (4),407-410。 5. Association of Official Analytical Chemists (AOAC). (1995) Official methods of analysis (16th ed.). Arlington, VA: AO AC. 6. Cha, Y. Y., Lee, E. 0., Lee, H. J., Park, Y. D, Ko, S. G., Kim, D. H., Kim, H. M., Kang, I. C. and Kim, S. H. (2004) Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clinica Chimica Acta, 348(1-2), 41- 48. 7. Cui, J. and Chisti, Y. (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses and production. Biotechnology Advances, 21(2), 109-122. 8. Cui, J., Goh, K. K., Archer, R. and Singh, H. (2007) Characterisation and bioactivity of protein-bound polysaccharides from submerged-culture fermentation of Coriolus versicolor Wr-74 and ATCC-20545 strains. Journal of Industrial Microbiology & Biotechnology, 34(5), 393-402. 9. Dai, Z., Liu, X., Ji, Z., Liu, L., Kang, H., Wang, X. and Diao, Y. (2008) The Effect-enhancing and Toxicity-reducing Action of the Extract of Herba Scutellariae Barbatae for Chemotherapy in Hepatoma H22 Tumor-bearing 21 2011166234. Lin Jingming, Liu Huang, Luo Rongcheng (Min 95) The research status of the chemical constituents and anti-tumor effects of Scutellaria barbata L., Chinese herbal medicine, 29 (4), 407-410. 5. Association of Official Analytical Chemists (AOAC). (1995) Official methods of analysis (16th ed.). Arlington, VA: AO AC. 6. Cha, YY, Lee, E. 0., Lee, HJ, Park, Y. D, Ko, SG, Kim, DH, Kim, HM, Kang, IC and Kim, SH (2004) Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clinica Chimica Acta, 348 (1-2), 41-48. 7. Cui, J. and Chisti, Y. (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses and production. Biotechnology Advances, 21(2), 109-122. Cui, J., Goh, KK, Archer, R. and Singh, H. (2007) Characterisation and bioactivity of protein-bound polysaccharides from submerged-culture fermentation of Coriolus versicolor Wr-74 and ATCC-20545 strains. Journal of Industrial Microbiology & Biotechnology, 34(5), 393-402. 9. Dai, Z., Liu, X., Ji, Z., Liu, L., Kang, H., Wang, X. and Diao, Y. ( 2008) The Effect-enhancing and Toxicity-reducing Action of The Extract of Herba Scutellariae Barbatae for Chemotherapy in Hepatoma H22 Tumor-bearing 21 201116623

Mice. Journal of Traditional Chinese Medicine, 28(3), 205-210. 10. Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A. and Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Analytical Chemistry, 28 (3), 350-356. 11. Ducki, S., Hadfield, J. A., Lawrence, N. J., Liu, C. Y., McGown, A. T. and Zhang, X. (1996) Isolation of E-l-(4-hydroxyphenyl)-but-l-en-3-one from Scutellaria barbata. Planta Medica, 62 (2), 185-186.Mice. Journal of Traditional Chinese Medicine, 28(3), 205-210. 10. Dubois, M., Gilles, KA, Hamilton, JK, Rebers, PA and Smith, F. (1956) Colorimetric method for determination of sugars and Analytical Chemistry, 28 (3), 350-356. 11. Ducki, S., Hadfield, JA, Lawrence, NJ, Liu, CY, McGown, AT and Zhang, X. (1996) Isolation of El-( 4-hydroxyphenyl)-but-l-en-3-one from Scutellaria barbata. Planta Medica, 62 (2), 185-186.

12. Hsieh, T. C., Kunicki, J., Darzynkiewicz, Z. and Wu, J. M. (2002) Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta-6, and -8 in promyelocj^ic HL-60 leukemic cells and mitogenically stimulated, and nonstimulated human lymphocytes. Journal of Alternative and Complementary Medicine, 8(5), 591-602. 13. Hsieh, T. C., Wu, P., Park, S. and Wu, J. M. (2006) Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity™ (PSP). BMC Complementary and Alternative Medicine, 6, 30. 14. Kizu, H., Imoto, Y., Tomimori, T., Kikuchi, T., Kadota, S. and Tsubono, K. (1997) Studies on the constituents of Scutellaria species. XVII. Structures of neo-clerodane-type diterpenoids from the whole herb of Scutellaria rivularis Wall. Chemical & pharmaceutical bulletin, 45(1), 152-160. 15. Kobayashi, H., Matsunaga, K. and Fujii, M. (1993) PSK as a chemopreventive agent. Cancer Epidemiology, Biomarkers Prevention, 2(3), 271-276. 16. Lee, C. L., Yang, X. and Wan, M. F. (2006) The culture duration affects the immunomodulatory and anticancer effect of polysaccharopeptide derived from Coriolus versicolor. Enzyme and Microbial Technology, 38(1-2), 14-21. 17. Lin, F. Y, Lai, Y. K., Yu, H. C., Chen, N. Y., Chang, C. Y., Lo, H. C. and Hsu, T. H. (2008) Effects of Lycium barbarum extract on production and immunomodulatory activity of the extracellular polysaccharopeptides fromr. 22 201116623 submerged fermentation culture of Coriolus versicolor. Food Chemistry. 110(2), 446-453. 18. Liu, F., Fung, M. C., Ooi, V. E. C. and Chang, S. T. (1996) Induction in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. Life Sciences, 58(21), 1795-1803. 19. Liu, W. K., Ng, T. B., Sze, S. F. and Tsui, K. W. (1993) Activation of peritoneal macrophages by polysaccharopeptide from the mushroom,12. Hsieh, TC, Kunicki, J., Darzynkiewicz, Z. and Wu, JM (2002) Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta-6, And -8 in promyelocj^ic HL-60 leukemic cells and mitogenically stimulated, and nonstimulated human lymphocytes. Journal of Alternative and Complementary Medicine, 8(5), 591-602. 13. Hsieh, TC, Wu, P., Park, S. and Wu, JM (2006) Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-YunityTM (PSP). BMC Complementary and Alternative Medicine, 6, 30. 14. Kizu, H., Imoto, Y., Tomimori, T., Kikuchi, T., Kadota, S. and Tsubono, K. (1997) Studies on the constituents of Scutellaria species. XVII. Structures of neo- Clerodane-type diterpenoids from the whole herb of Scutellaria rivularis Wall. Chemical & pharmaceutical bulletin, 45(1), 152-160. 15. Kobayashi, H., Matsunaga, K. and Fujii, M. ( 1993) PSK as a chemopreventive agent. Cancer Epidemiology, Biomarkers Prevention, 2(3), 271-276. 16. Lee, CL, Yang, X. and Wan, MF (2006) The culture duration affects the immunomodulatory and anticancer effect of Polysaccharopeptide derived from Coriolus versicolor. Enzyme and Microbial Technology, 38(1-2), 14-21. 17. Lin, F. Y, Lai, YK, Yu, HC, Chen, NY, Chang, CY, Lo, HC and Hsu, TH (2008) Effects of Lycium barbarum extract on production and immunomodulatory activity of the extracellular polysaccharopeptides from r. 22 201116623 submerged fermentation culture of Coriolus versicolor. Food Chemistry. 110(2), 446-453. 18. Liu, F., Fung, MC, Ooi, VEC and Chang, ST (1996) Induction in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. Life Sciences, 58(21), 1795-1803. 19. Liu, WK, Ng , TB, Sze, SF and Tsui, KW (1993) Activation of peritoneal macrophages by polysaccharopeptide from the mushro Om,

Coriolus versicolor. Immunopharmacology, 26(2), 139-146. 20. Mata, Y. N., Blazquez, M. L., Ballester, A. Gonzalez, F. and Munoz. J. A.Coriolus versicolor. Immunopharmacology, 26(2), 139-146. 20. Mata, Y. N., Blazquez, M. L., Ballester, A. Gonzalez, F. and Munoz. J. A.

(2009) Sugar-beet pulp pectin gels as biosorbent for heavy metals: Preparation and determination of biosorption and desorption characteristics. Chemical Engineering Journal, 150(2-3), 289-301. 21. Moradali, M. F., Mostafavi, H., Ghods, S. and Hedjaroude, G. A. (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology, 7 (6), 701-724. 22. Muller, K. and Meineke, V. (2007) Radiation-induced alterations in cytokine production by skin cells. Experimental Hematology, 35(4), 96-104. 23. Ng, T. B. (1998) A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). General Pharmacology, 30(1), 1-4. 24. Ng, T. B. and Chan, W. Y. (1997) Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice. General Pharmacology, 29(2), 269-273. 25. Pang, Z. J., Zhou, M., Chen Y. and Wan, J. (1998) A protein-bound 23 201116623 polysaccharide synergistic with lipopolysaccharide induces nitric oxide release and antioxidant enzyme activities in peritoneal macrophages.(2009) Sugar-beet pulp pectin gels as biosorbent for heavy metals: Preparation and determination of biosorption and desorption characteristics. Chemical Engineering Journal, 150(2-3), 289-301. 21. Moradali, MF, Mostafavi, H., Ghods, S. and Hedjaroude, GA (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology, 7 (6), 701-724. 22. Muller, K. and Meineke, V. (2007 Radiation-induced alterations in cytokine production by skin cells. Experimental Hematology, 35(4), 96-104. 23. Ng, TB (1998) A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). General Pharmacology, 30(1), 1-4. 24. Ng, TB and Chan, WY (1997) Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not artificial adverse effects on female reproductive Or embryonic development in mice. General Pharmacolog y, 29(2), 269-273. 25. Pang, ZJ, Zhou, M., Chen Y. and Wan, J. (1998) A protein-bound 23 201116623fruit synergistic with lipopolysaccharide induces nitric oxide release and antioxidant enzyme Activities in peritoneal macrophages.

American Journal of Chinese medicine, 26(2), 133-141. 26. Rau, U., Kuenz, A., Wray, V., Nimtz, M., Wrenger, J. and Cicek, H. (2009)American Journal of Chinese medicine, 26(2), 133-141. 26. Rau, U., Kuenz, A., Wray, V., Nimtz, M., Wrenger, J. and Cicek, H. (2009)

Production and structural analysis of the polysaccharide secreted by Trametes (Coriolus) versicolor ATCC 200801. Applied Microbiology and Biotechnology, 81(5), 827-837. 27. Sandula, J.,Kogan, G, Kacurakova, M. and Machova,E· (1999) Microbial (1—3)- -D-glucans, their preparation, physico-chemical characterizationProduction and structural analysis of the polysaccharide secreted by Trametes (Coriolus) versicolor ATCC 200801. Applied Microbiology and Biotechnology, 81(5), 827-837. 27. Sandula, J., Kogan, G, Kacurakova, M. and Machova, E · (1999) Microbial (1-3)--D-glucans, their preparation, physico-chemical characterization

and immunomodulatory activity. Carbohydrate Polymers, 38(3), 247-253. 28. Spelman, K., Bums, J. J., Nichols, D., Winters, N., Ottersberg, S. andAnd immunomodulatory activity. Carbohydrate Polymers, 38(3), 247-253. 28. Spelman, K., Bums, J. J., Nichols, D., Winters, N., Ottersberg, S. and

Tenborg, M. (2006) Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Alternative Medicine Review, 11(2), 128-150. 29. Spencer, J.W. (1999) Essential issues in complementary/altemative medicine. In: J.W. Spencer. & J.J. Jacobs. (Eds.), Complementary/Alternative Medicine. An Evidence-based Approach. Mosby Inc (pp. 3-36). St. Louis, Mo, USA. 30. Tavares, A. P., Coelho, M. A., Agapito, M. S., Coutinho, J. A. and Xavier, A. M. (2005) Optimization and modeling of laccase production by Trametes versicolor in a bioreactor using statistical experimental design. Applied Biochemistry and Biotechnology, 134(3), 233-248. 31. Ueno, S., Yoshikummi, C., Hirosem, F. Omura, Y., Wada, T. and Fujii, T. (1980) Method of producing nitrogen-containing polysaccharides. U.S. Patent 4,202,969. 32. Wang, Η. X., Ng, T. B., Liu, W. K.5 Ooi, V. E. and Chang, S. T. (1996) Polysaccharide-peptide complexes from the cultured mycelia of the 24 201116623 mushroom Coriolus versicolor and their culture medium activate mouse ljmiphoc^es and macrophages. The International Journal of Biochemistry & Cell Biology, 28(5), 601-607. 33. Wang, Y. X. and Lu, Z. X. (2005) Optimization of processing parameters for the mycelial growth and extracellular polysaccharide production by Boletus spp.ACCC 50328. Process Biochemistry, 40(3-4), 1043-1051. 34. Wang, Y.s Xue, X, Xiao, Y., Zhang, F, Xu, Q. and Liang, X. (2008) Purification and preparation of compounds from an extract of Scutellaria barbata D. Don using preparative parallel high performance liquid chromatography. Journal of Separation Science, 31(10), 1669- 1676.Tenborg, M. (2006) Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Alternative Medicine Review, 11(2), 128-150. 29. Spencer, JW (1999) Essential issues in complementary/altemative medicine. In: JW Spencer. & JJ Jacobs. (Eds.), Complementary/Alternative Medicine. An Evidence-based Approach. Mosby Inc (pp. 3-36). St. Louis, Mo, USA. 30. Tavares, AP, Coelho, MA, Agapito, MS, Coutinho, JA and Xavier, AM (2005) Optimization and modeling of laccase production by Trametes versicolor in a bioreactor using statistical experimental design. Applied Biochemistry and Biotechnology, 134(3), 233-248. Ueno, S., Yoshikummi, C., Hirosem, F. Omura, Y., Wada, T. and Fujii, T. (1980) Method of producing nitrogen-containing polysaccharides. US Patent 4,202,969. 32. Wang, Η. X., Ng, TB, Liu, WK5 Ooi, VE and Chang, ST (1996) Polysaccharide-peptide complexes from the cultured mycelia of the 24 201116623 mushroom Coriol Us versicolor and their culture medium activate mouse ljmiphoc^es and macrophages. The International Journal of Biochemistry & Cell Biology, 28(5), 601-607. 33. Wang, YX and Lu, ZX (2005) Optimization of processing parameters for The mycelial growth and extracellular polysaccharide production by Boletus spp. ACCC 50328. Process Biochemistry, 40(3-4), 1043-1051. 34. Wang, Ys Xue, X, Xiao, Y., Zhang, F, Xu, Q. And Liang, X. (2008) Purification and preparation of compounds from an extract of Scutellaria barbata D. Don using preparative parallel high performance liquid chromatography. Journal of Separation Science, 31(10), 1669-1676.

35. Wang, Z. Q., Xu, F. M., Yan, X. Z. and Zhu, Y. (1996) Scutebarbatine A, a new neoclerodane-type diterpenoid alkaloid from Scutellaria barbata. Chinese Chemical Letters. 7(4), 333-334. 36. Wasser, S. P. (2005) Reishi or Ling Zhi (Ganoderma lucidum). Encyclop Diet Suppl. 603-622. 37. Wasser, S. P. and Weis, A. L. (1999) Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modem perspective. Critical Reviews in Immunology, 19(1), 65-96. 38. Yang, L. and Zhang, L. M. (2009) Chemical structural and chain conformational characterization of some bioactive polysaccharides isolated from natural sources. Carbohydrate Polymers^ 76(3), 349-361. 39. Yang, Q. Y. and Zhou, Y. F. (1993) A protein bound polysaccharide-PSP. In Proceedings of PSP International Symposium (Edited by Yang Q. Y. and Kwok, C. Y.). Fundan University Press, Shanghai, China. 22-34. 40. Yin, X., Zhou, J. and Jie, C. (2004) Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sciences, 75(18), 2233-2244. 41. Yu, J. and Lei, J. (2004) Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata. Phytochemistry, 65(7), 881-884. 25 201116623 【圖式簡單說明】 圖一:傅式紅外線分析儀(FTIR)分析多醣肽圖譜,其中 ePSP-Cv表示雲芝胞外多醣肽;ePSP-Cv-SBE表示半枝蓮雲 芝胞外多醣肽;PSP-SB表示半枝蓮多醣肽。 圖二:不同多醣肽對巨噬細胞RAW264.7增生之影響; 統計分析顯著性差異(P < 〇_〇5)以英文字母標示於立柱上方。 圖三:不同多醣肽誘導巨噬細胞RAW264.7產生一氧化 氮量之比較。黑柱表示無添加LPS,灰柱表示添加LPS ;統 計分析顯著性差異(P < 〇.〇5)以英文字母標示於立柱上方。 圖四:不同多醣肽誘導巨噬細胞RAW264.7產生細胞激 素TNF-α之影響。黑柱表示無添加LPS,灰柱表示添加LPS ; 統計分析顯著性差異(P < 〇·〇5)以英文字母標示於立柱上方。 圖五:不同多醣肽誘導巨噬細胞RAW264.7產生細胞激 素IL-Ιβ之影響。黑柱表示無添加LPS,灰柱表示添加LPS ; 統計分析顯著性差異(P < 〇.〇5)以英文字母標示於立柱上方。 圖六:不同多醣肽誘導巨噬細胞RAW264.7產生細胞激 素IL-6之影響。黑柱表示無添加LPS,灰柱表示添加LPS ; 統計分析顯著性差異(P < 〇·〇5)以英文字母標示於立柱上方。 【主要元件符號說明】 26 20111662335. Wang, ZQ, Xu, FM, Yan, XZ and Zhu, Y. (1996) Scutebarbatine A, a new neoclerodane-type diterpenoid alkaloid from Scutellaria barbata. Chinese Chemical Letters. 7(4), 333-334. Wasser, SP (2005) Reishi or Ling Zhi (Ganoderma lucidum). Encyclop Diet Suppl. 603-622. 37. Wasser, SP and Weis, AL (1999) Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modem perspective. Critical Reviews in Immunology, 19(1), 65-96. 38. Yang, L. and Zhang, LM (2009) Chemical structural and chain conformational characterization of some bioactive polysaccharides isolated from natural sources. Carbohydrate Polymers^ 76(3), 349 -361. 39. Yang, QY and Zhou, YF (1993) A protein bound polysaccharide-PSP. In Proceedings of PSP International Symposium (Edited by Yang QY and Kwok, CY). Fundan University Press, Shanghai, China. 22-34 40. Yin, X., Zhou, J. and Jie, C. (2004) Anticancer activity and mechanism of Scutellaria barbata extract on human l Eng cancer cell line A549. Life Sciences, 75(18), 2233-2244. 41. Yu, J. and Lei, J. (2004) Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata. Phytochemistry, 65(7) ), 881-884. 25 201116623 [Simple description of the diagram] Figure 1: Analysis of polysaccharide peptide by Fu-Fin Infrared Analyzer (FTIR), in which ePSP-Cv represents Yunzhi extracellular polysaccharide peptide; ePSP-Cv-SBE represents half-branched Lianyunzhi extracellular polysaccharide peptide; PSP-SB represents Scutellaria barbata polysaccharide peptide. Figure 2: Effect of different polysaccharide peptides on macrophage RAW264.7 proliferation; statistical analysis significant differences (P < 〇 _ 〇 5) marked with English letters above the column. Figure 3: Comparison of the amount of nitric oxide produced by macrophages RAW264.7 induced by different polysaccharide peptides. Black bars indicate no added LPS, gray bars indicate addition of LPS; statistical analysis significant differences (P < 〇.〇5) are indicated above the column in English letters. Figure 4: Effect of different polysaccharide peptides on the production of cytokine TNF-α by macrophage RAW264.7. Black bars indicate no added LPS, gray bars indicate addition of LPS; statistical analysis significant differences (P < 〇·〇5) are indicated above the column in English letters. Figure 5: Effect of different polysaccharide peptides on the production of cytokines IL-Ιβ by macrophage RAW264.7. Black bars indicate no added LPS, gray bars indicate addition of LPS; statistical analysis significant differences (P < 〇.〇5) are indicated above the column in English letters. Figure 6: Effect of different polysaccharide peptides on the production of cytokines IL-6 by macrophage RAW264.7. Black bars indicate no added LPS, gray bars indicate addition of LPS; statistical analysis significant differences (P < 〇·〇5) are indicated above the column in English letters. [Main component symbol description] 26 201116623

+ SBE -SBE ePSP-Cv-SBE ePSP-Cv PSP-SB -LPS + LPS Untreated 添加半枝蓮萃取液 未添加半枝蓮萃取液 半枝蓮雲芝胞外多醣肽 雲芝胞外多醣肽 半枝蓮多醣肽 未添加脂多醣 添加脂多醣 對照組 TNF-α腫瘤壞死因子-a ( Tumor Factor-α )+ SBE -SBE ePSP-Cv-SBE ePSP-Cv PSP-SB -LPS + LPS Untreated Adding Scutellaria barbata extract without adding Scutellaria barbata extract Scutellaria barbata exopolysaccharide peptide Yunzhi extracellular polysaccharide peptide half branch Lotus polysaccharide peptide without added lipopolysaccharide plus lipopolysaccharide control group TNF-α tumor necrosis factor-a (Tumor Factor-α )

Il-ΐβ 介白素-1β (Interleukin-ΐβ) 11_6 介白素-6 (Interleukin-6)Il-ΐβ interleukin-1β (Interleukin-ΐβ) 11_6 Interleukin-6

NecrosisNecrosis

2727

Claims (1)

201116623 七、申請專利範圍: 種具有阿拉伯糖之雲苳胞外多醋肽,其係產生自添加 年生或多年生草本植物萃取物於雲芝菌種之培養基 中。 2. 如申請專利範圍第1項所述之具有阿拉伯糖之雲芝胞外 夕酶肽’該雲k菌種之品系為LH1, 寄存於食品工業發展研究所生物資源保存中心,登錄號 碼為 BCRC 930112。 3. 如申請專利範圍第1項所述之具有阿拉伯糖之雲芝胞外 多醣肽,該一年生或多年生草本植物萃取物為唇形科黃 答屬植物萃取物。 4 ·如申s肖專利範圍第3項所述之具有阿拉伯糖之雲芝胞外 多醋肽’該唇形科黃芩屬植物為半枝蓮(& barbata ) ψ ^ 〇 5·如申請專利範圍第1項所述之具有阿拉伯糖之雲芝胞外 多酿狀’係將雲芝菌種經液態培養基進行深層培養後, 分離之產物者。 6. 如申請專利範圍第5項所述之具有阿拉伯糖之雲芝胞外 多聽肽’其液態培養基包含以碳源、氮源及鹽類為營養 物組成者。 7. 如申請專利範圍第6項所述之具有阿拉伯糖之雲芝胞外 多醣肽,其液態培養基包含以葡萄糖為碳源、蛋白脒為 28 201116623 I源’磷酸二氫鉀(ΚΗ2Ρ〇4)及硫酸鎂(MgS04.7H20) 為鹽類之營養物組成者。 8.如申請專利範圍第7項所述之具有阿拉伯糖之雲芝胞外 多酶肚·’其液態培養基包含以10%以下葡萄糖為碳源、 3%以下蛋白腺為氮源,2%以下磷酸二氫鉀(KH2P〇4) 及2%以下硫酸鎂(MgS04.7H20)為鹽類之營養物組成 者。 • 9.如申請專利範圍第4項所述之具有阿拉伯糖之雲芝胞外 多醣肽,其液態培養基包含之半枝蓮萃取物為5%以下。 10. —種具有阿拉伯糖之雲芝胞外多醣肽生產方法,包含: 配製液態培養基; 添加一年生或多年生草本植物萃取物於該液態培養基; 接種雲芝菌種於該液態培養基中; 進行深層培養;以及 • 分離經深層培養後之產物者。 11. 如申請專利範圍第10項所述之具有阿拉伯糖之雲芝胞 外多聽肽生產方法,該雲芝菌種之品系為 verhco/orLH1,寄存於食品工業發展研究所生物資源保 存中心,登錄號碼為BCRC 930112。 如申味專利範圍第10項所述之具有阿拉伯糖之雲芝胞 外多醣肽生產方法,該一年生或多年生草本植物萃取物 為唇形科黃芩屬植物萃取物。 29 201116623 13.如申請專利範圍第12項所述之具有阿拉伯糖之雲芝胞 外多醣肽生產方法,該唇形科黃芩屬植物為半枝蓮 (Scutellaria barbata)萃取物。 14·如申請專利範圍第10項所述之具有阿拉伯糖之雲芝胞 外多醣肽生產方法,其液態培養基包含以碳源、氮源及 鹽類為營養物組成者。 15·如申請專利範圍第14項所述之具有阿拉伯糖之雲芝胞 • 外多醣肽生產方法,其液態培養基包含以葡萄糖為碳 源、蛋白腺為氮源,磷酸二氫鉀(KH2P〇4 )及硫酸鎂 (MgSCV7H2〇 )為鹽類為營養物組成者。 16.如申請專利範圍第15項所述之具有阿拉伯糖之雲芝胞 外多醣肽生產方法,其液態培養基包含以1〇%以下葡萄 糖為碳源、3%以下蛋白.腺為氮源,2%以下磷酸二氫鉀 (KH2P〇4)及2%以下硫酸鎂(MgS〇4.7H2〇)為鹽類之 • 營養物組成者。 17·如申請專利範圍第13項所述之具有阿拉伯糖之雲芝胞 外多醣肽生產方法,其液態培養基包含之半枝蓮萃取物 為5 %以下。 18·—種具有阿拉伯糖之雲芝胞外多醣肽組合物,包含如申 請專利範圍第5.項所述之產物者,及以含稀釋劑、賦型 劑、載體或配方組成之組合物。 I9·—種具有阿拉伯糖之雲芝胞外多醣肽組合物,包含如申 30 201116623 請專利範圍第ι〇項所述之產物者,及以含稀釋劑、賦型 劑、載體或配方組成之組合物。201116623 VII. Patent application scope: A kind of extracellular multi-peptide peptide with arabinose, which is produced from the medium of adding annual or perennial herb extracts to the Yunzhi strain. 2. The strain of the Yunzhi extracellular enzyme peptide with arabinose as described in the first paragraph of the patent application is the LH1 strain, which is deposited in the Bioresource Conservation Center of the Food Industry Development Research Institute. The registration number is BCRC. 930112. 3. The extract of the annual or perennial herbaceous plant extract of the genus Ganoderma lucidum, as described in claim 1, is an extract of the genus Astragalus. 4 · The extracellular polyglycolic peptide of Agaricus chinensis with the arabinose as described in the third paragraph of the patent scope of the application of the sho sho. 'The genus Astragalus is a scutellaria (& barbata) ψ ^ 〇5·If applying for a patent The extracellular multi-branched type of the ganoderma lucidum having the arabinose described in the first item is a product obtained by subjecting the Yunzhi strain to a deep culture in a liquid medium. 6. The extracellular peptide of the genus Yunzhi with arabinose as described in claim 5, wherein the liquid medium comprises a carbon source, a nitrogen source and a salt as a nutrient. 7. The liquid medium containing arabinose as described in claim 6 of the patent scope, wherein the liquid medium comprises glucose as a carbon source and peptone is 28 201116623 I source 'potassium dihydrogen phosphate (ΚΗ2Ρ〇4) And magnesium sulfate (MgS04.7H20) is a nutrient component of the salt. 8. The extracellular multi-enzyme of Yunzhi with arabinose as described in claim 7 of the patent application. The liquid medium comprises 10% or less of glucose as a carbon source and 3% or less of a protein gland as a nitrogen source, and 2% or less. Potassium dihydrogen phosphate (KH2P〇4) and 2% or less magnesium sulfate (MgS04.7H20) are the nutrient components of the salt. 9. The ganoderma lucidum extracellular polysaccharide peptide having arabinose as described in claim 4, wherein the liquid medium comprises a scutellaria extract of 5% or less. 10. A method for producing an extracellular polysaccharide peptide of yoghurt having arabinose, comprising: preparing a liquid medium; adding an annual or perennial herb extract to the liquid medium; inoculating the Yunzhi strain in the liquid medium; performing deep culture ; and • Separation of products after deep culture. 11. The method for producing an extracellular peptide of Yunzhi with a gum arabic as described in claim 10, wherein the strain of Yunzhi is Verhco/orLH1, and is deposited in the Biological Resource Conservation Center of the Food Industry Development Research Institute. The login number is BCRC 930112. The method for producing an exopolysaccharide peptide of the arabinose as described in claim 10, wherein the annual or perennial herb extract is an extract of the genus Astragalus. The method of producing the ganoderma lucidum extracellular polysaccharide peptide having arabinose according to the invention of claim 12, wherein the plant of the genus Astragalus is a Scutellaria barbata extract. 14. The method for producing an exopolysaccharide peptide having an arabinose according to claim 10, wherein the liquid medium comprises a carbon source, a nitrogen source and a salt as a nutrient. 15. The method for producing a cyanosugar-free exopolysaccharide peptide having arabinose according to claim 14, wherein the liquid medium comprises glucose as a carbon source, protein gland as a nitrogen source, and potassium dihydrogen phosphate (KH2P〇4). And magnesium sulfate (MgSCV7H2〇) is a salt that is a nutrient component. 16. The method for producing an exopolysaccharide peptide having an arabinose according to claim 15, wherein the liquid medium comprises less than 1% glucose as a carbon source, 3% or less protein, and a gland as a nitrogen source, 2 The following potassium dihydrogen phosphate (KH2P〇4) and 2% or less magnesium sulfate (MgS〇4.7H2〇) are the nutrient components of the salt. 17. The method for producing an exopolysaccharide peptide having an arabinose according to claim 13, wherein the liquid medium comprises a scutellaria extract of 5% or less. 18. A species of yoghurt extracellular polysaccharide peptide having arabinose, comprising a product as described in claim 5, and a composition comprising a diluent, an excipient, a carrier or a formulation. I9·-A kind of yoghurt extracellular polysaccharide peptide composition having arabinose, comprising the product as described in claim 30 201116623, the scope of the patent, and comprising a diluent, a excipient, a carrier or a formulation. combination. 3131
TW98137173A 2009-11-03 2009-11-03 Extracellular polysaccharides with arabinose from trametes versicolor lh1 and enhancing their production methods TWI379001B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98137173A TWI379001B (en) 2009-11-03 2009-11-03 Extracellular polysaccharides with arabinose from trametes versicolor lh1 and enhancing their production methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98137173A TWI379001B (en) 2009-11-03 2009-11-03 Extracellular polysaccharides with arabinose from trametes versicolor lh1 and enhancing their production methods

Publications (2)

Publication Number Publication Date
TW201116623A true TW201116623A (en) 2011-05-16
TWI379001B TWI379001B (en) 2012-12-11

Family

ID=44934875

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98137173A TWI379001B (en) 2009-11-03 2009-11-03 Extracellular polysaccharides with arabinose from trametes versicolor lh1 and enhancing their production methods

Country Status (1)

Country Link
TW (1) TWI379001B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110927282A (en) * 2019-12-11 2020-03-27 浙江华康药业股份有限公司 Method for quickly quantifying various monosaccharide components in xylose mother liquor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110927282A (en) * 2019-12-11 2020-03-27 浙江华康药业股份有限公司 Method for quickly quantifying various monosaccharide components in xylose mother liquor

Also Published As

Publication number Publication date
TWI379001B (en) 2012-12-11

Similar Documents

Publication Publication Date Title
Zhang et al. Advance in Cordyceps militaris (Linn) Link polysaccharides: Isolation, structure, and bioactivities: A review
Zhao et al. Immunomodulatory effects of edible and medicinal mushrooms and their bioactive immunoregulatory products
Kothari et al. Anticancer and other therapeutic relevance of mushroom polysaccharides: A holistic appraisal
Wasser Medicinal mushroom science: history, current status, future trends, and unsolved problems
Wasser Medicinal mushroom science: Current perspectives, advances, evidences, and challenges
Rathee et al. Mushrooms as therapeutic agents
Sanodiya et al. Ganoderma lucidum: a potent pharmacological macrofungus
Boh Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs
Sarangi et al. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans
Lindequist et al. The pharmacological potential of mushrooms
Chandrasekaran et al. Properties and potential applications of the culinary-medicinal cauliflower mushroom, Sparassis crispa Wulf.: Fr.(Aphyllophoromycetideae): a review
Li et al. Structural characterization and immunomodulatory activity of a polysaccharide from Eurotium cristatum
TWI724352B (en) Polysaccharide fermentation compositioncapable of anti-cancer, anti-virus, anti-inflammatory, promoting osteoblast proliferation, promoting intestinal stem cell proliferation effects and preparation method thereof.
SG174110A1 (en) New ganoderma tsugae var. jannieae strain tay-i and biologically active biomass and extracts therefrom
Surayot et al. Structural characterization of a polysaccharide from Certaria islandica and assessment of immunostimulatory activity
Sharma et al. Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review
Yan et al. New polysaccharide compounds derived from submerged culture of Ganoderma lucidum and Lycium barbarum
Gafforov et al. Ganoderma adspersum (Schulzer) Donk; Ganoderma applanatum (Pers.) Pat.; Ganoderma lucidum (Curtis) P. Karst.; Ganoderma resinaceum Boud.-GANODERMATACEAE
TW201116623A (en) Extracellular polysaccharides with arabinose from Trametes versicolor LH1 and enhancing their production methods
CN113105567B (en) Paecilomyces cicadae mannan and preparation and application thereof
KR20120019311A (en) Composition for immunostimulation which comprises polysaccharide from fermented ginseng with phellinus linteus to enhance the immune function
WO2009017463A2 (en) NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE
Zhang et al. Antioxidative and immunomodulatory activities of the exopolysaccharides from submerged culture of hen of the woods or maitake culinary-medicinal mushroom, Grifola frondosa (Agaricomycetes) by addition of Rhizoma Gastrodiae extract and its main components
Kim et al. Immune enhancement of Hericium erinaceum mycelium cultured in submerged medium supplemented with ginseng extract
Gurusamy et al. Effect of medicinal mushroom, Auricularia auriculajudae, polysaccharides against EAC cell lines

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees